YIGSR
YIGSR is a peptide that can inhibit the tumour growth and metastasis of leukaemic cells[1]. YIGSR blocks the cellular binding to laminin I via a 67-kDa laminin-binding protein, and inhibits shear-induced increase in eNOS expression of laminin cells[2].
Product Specifications
CAS Number
110590-64-2
Product Name Alternative
Laminin Fragment 929-933
UNSPSC
12352209
Hazard Statement
H302-H315-H319-H335
Target
NO Synthase
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yigsr.html
Purity
99.28
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
N=C(N)NCCC[C@@H](C(O)=O)NC([C@H](CO)NC(CNC([C@H]([C@@H](C)CC)NC([C@H](CC1=CC=C(C=C1)O)N)=O)=O)=O)=O
Molecular Formula
C26H42N8O8
Molecular Weight
594.66
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD5 (Mantle Cell Lymphoma Marker) (CD5/2416), CF640R conjugate, 0.1mg/mL
